non alcoholic fatty liver disease. Fatty (change of) liver, not elsewhere classified
Conditions
Interventions
Intervention 1: IN intervention group: 500mg L- carnitine, two times a day, as well as recommendation for exercise, weight loss and low fat diet, for six months. Intervention 2: Contol group: recommen
Treatment - Drugs
IN intervention group: 500mg L- carnitine, two times a day, as well as recommendation for exercise, weight loss and low fat diet, for six months
Contol group: recommendations for exercise, weight loss, and low fat diet for 6 months
Sponsors
Gasrtoenterology Research Centre Of Imam Reza Hospital
Eligibility
Sex/Gender
All
Age
14 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria: serum level of alanin aminotranspherase and aspartat aminotranspherase more than 40mg, ultrasonograghy evidences of fatty liver Exclusion criteria: overt diabetes, TG serum over 500mg, other causes of increasing liver enzymes such as viral infections, hemochromatosis , Wilson’s disease, autoimmune diseases, drinking (20 and 10 grams per day for men and women, respectively)
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum level of alanine aminotransferase. Timepoint: Before intervention and six months after initiation of the intervention. Method of measurement: measuring serum level. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum level of aspartate aminotransferase. Timepoint: Before intervention and six months after initiation of the intervention. Method of measurement: by serum level measurement.;Fatty liver grading. Timepoint: befor intervention and six months after initiation intervention. Method of measurement: by ultasonography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactArezo Judaki
Tabriz University of Medical Sciences
Outcome results
None listed